UBS Group
ONSIW

UBS Group’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

UBS Group’s Portfolio ONSIW Stock Details ONSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,600
Closed – – 8509
2018
Q2 		$0 Sell
2,600
-2,929
-53% -$108 ﹤0.01% 8480
2018
Q1 		$0 Buy
+5,529
New +$223 ﹤0.01% 8427
2017
Q4 		– Sell
-7,888
Closed -$1K – 8297
2017
Q3 		$1K Buy
+7,888
New +$1.01K ﹤0.01% 7641
2017
Q1 		– Sell
-1,110
Closed – – 8234
2016
Q4 		$0 Sell
1,110
-2,919
-72% -$926 ﹤0.01% 8246
2016
Q3 		$2K Buy
4,029
+3,279
+437% +$1.49K ﹤0.01% 7457
2016
Q2 		$0 Buy
+750
New +$287 ﹤0.01% 8149

Other funds holding ONSIW

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

UBS Group's ONSIW Position: Q3 2018 in Review

UBS Group sold out of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q3 2018, closing a stake of 2,600 shares.

UBS Group first reported a position in ONSIW in Q2 2016 and held it in 6 quarters. The position peaked at $2K in Q3 2016. 6 funds tracked by Wall St. Rank hold ONSIW as of Q3 2018.

  • UBS Group reported no remaining Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position as of Q3 2018 after selling out during the quarter.
  • UBS Group sold 2,600 Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 shares in Q3 2018.
  • UBS Group first reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in Q2 2016 and held it in 6 quarters.
  • UBS Group's Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position peaked at $2K in Q3 2016.
  • 6 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q3 2018.

Based on UBS Group's 13F filing for Q3 2018, filed 14 Nov 2018.